Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576407 · ClinicalTrials.gov registry record · Phase 2
Thymus Transplantation in DiGeorge Syndrome #668
A Phase 2 study, sponsored by Sumitomo Pharma Switzerland.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00576407: Completed Phase 2 study, sponsored by Sumitomo Pharma Switzerland.
NCT00576407 is a Phase 2 study that has completed, run by Sumitomo Pharma Switzerland. The registered enrollment target is 26 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00576407, a Phase 2 study, has completed, sponsored by Sumitomo Pharma Switzerland.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
The study purpose is to determine whether cultured thymus tissue implantation (CTTI) is effective in treating typical complete DiGeorge syndrome.
Primary Outcome
Survival at 1 year post CTTI was assessed using the Kaplan Meier Estimated Survival. This mathematical function estimates the survival for a certain length of time.
Interventions
- BIOLOGICAL Cultured Thymus Tissue for Implantation (CTTI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 1991-10 |
| Est. Completion | 2017-12-31 |
| Phase | Phase 2 |
What the finished NCT00576407 record still lists
NCT00576407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which Cultured Thymus Tissue for Implantation (CTTI) is the first listed.
NCT00576407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00576407 about?
NCT00576407 is a clinical study titled "Thymus Transplantation in DiGeorge Syndrome #668". The study purpose is to determine whether cultured thymus tissue implantation (CTTI) is effective in treating typical complete DiGeorge syndrome.
What is the current status of trial NCT00576407?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 1991-10. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT00576407?
The interventions under investigation include: Cultured Thymus Tissue for Implantation (CTTI) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00576407?
This trial is sponsored by Sumitomo Pharma Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00576407's enrollment target sits among peer trials
26 1708th of 2000 higher than 282 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia